RxDoctor Payments Data

Amanda Fidiam, PA

Medical · Moosic, PANPI 1003193202

Payments from drug & device makers

$714in general payments, 2019–2025

Across 47 payments — averaging $15.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$270
  • Supernus Pharmaceuticals, Inc.$168
  • Ironshore Pharmaceuticals Inc.$105
  • Takeda Pharmaceuticals U.S.A., Inc.$47
  • Otsuka America Pharmaceutical, Inc.$22
  • Eisai Inc.$21
  • plus $81 from 5 others

What the payments were for

  • Food & beverage$714100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$714 in reported general payments places this provider in the 60th percentile of 2,594 medical providers in Pennsylvania.

See all medical providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$4,058
Medicare patients
12
Services billed
39

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
VraylarCariprazine Hcl15$20,872
RexultiBrexpiprazole14$19,238
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine39$872
Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine15$858
Desvenlafaxine Succinate ErDesvenlafaxine Succinate18$732
Clonazepam52$457
Duloxetine Hcl34$380
Lamotrigine13$344
Clomipramine Hcl15$341
Alprazolam XrAlprazolam15$280
Alprazolam51$273
Sertraline Hcl31$182
Bupropion XlBupropion Hcl12$163
Aripiprazole12$102
Lorazepam11$72

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieVraylar$270$20,87215 claims
Otsuka America Pharmaceutical, Inc.Rexulti$22$19,23814 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 2,594 medical providers in Pennsylvania.

Other medical in Moosic

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →